tm logo
ULIBDI
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 13 May 2024

Last Applicant/ Owned by

3050 Science Park Rd.

San Diego

CA

92037

Serial Number

97560320 filed on 23rd Aug 2022

Registration Number

N/A

Correspondent Address

Heather Heft

Heather Heft Merck & Co., Inc.

Office of General Counsel

Rahway, NJ 07065

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

ULIBDI

Medical laboratory services, namely, laboratory testing for scientific research purposes and medical research services; medical laboratory services, namely, laboratory testing for scientific research purposes in the field of disease management and gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic s Read More

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Health care services, namely, disease management programs; medical services, namely, providing medical information to health care providers, managed care providers and patients via computer networks; providing health information in the field of gastrointestinal diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; providing information relating to medical diagnostic testing; providing information relating to medical treatment recommendation; medical consultation; providing a website featuring information about medical services for the diagnosis, prevention, and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer; medical diagnostic testing provided by medical laboratories; medical analysis services in the nature of laboratory testing for disease management and patient diagnosis and patient selection for the diagnosis and treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, provided by medical laboratories; medical analysis services relating to the treatment of patients in the nature of laboratory testing for the purpose of immune modulation and management of side effects associated with renal disorders and cancer, provided by medical laboratories


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Medical laboratory services, namely, laboratory testing for scientific research purposes and medical research services; medical laboratory services, namely, laboratory testing for scientific research purposes in the field of disease management and gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems; medical laboratory services, namely, laboratory testing for scientific research of immune modulation and management of side effects associated with renal disorders and cancer pathology; medical laboratory services, namely, laboratory testing for scientific research of patient disease diagnoses and for patient selection for clinical trials


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations used for the treatment of gastrointestinal disorders and diseases, colitis, Crohn's disease, Inflammatory Bowel Disease, systemic sclerosis, Interstitial Lung Disease, Systemic sclerosis-associated interstitial lung disease, arthritis, and other diseases of the immune, digestive, bowel, skin, joint, lung, liver, kidney, bile duct, or gastrointestinal systems, immune modulation and management of side effects associated with renal disorders and cancer


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for clinical or medical laboratory use


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97560320

Mark Type

No Service Mark

Attorney Docket Number

No 214705020100

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Nov 2024SOU TEAS EXTENSION RECEIVED
11th Nov 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
11th Nov 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11th Nov 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11th Nov 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14th May 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th May 2024SOU EXTENSION 1 GRANTED
13th May 2024SOU EXTENSION 1 FILED
13th May 2024SOU TEAS EXTENSION RECEIVED
05th Dec 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT